ZOGENIX EUROPE LIMITED
Company number 07275920 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£4,397,497
Balance sheet as at 2019-12-31
What it does
Company ceased to provide sales and marketing services to its parent company and the service agreement is no longerapplicable (company ceased trading from 01st January 2018). The director's may dissolve the company in a near future.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2010-06-07
- Registered office
- 208 Bath Road, Slough, Berkshire, United Kingdom, SL1 3WE
- Postcode
- SL1 3WE
- Capital
- 5,621,790 USD
- Accounts category
- Small
- Charges
- 1 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-06-07
- Next due by
- 2027-06-21
Nature of business (SIC)
- 21100 Manufacture of basic pharmaceutical products
- 21200 Manufacture of pharmaceutical preparations
Officers 2 current · 7 resigned
Group structure 1 subsidiary
Controlled by Ucb Biosciences Inc. (01217127) — since 2024-04-01
From persons-with-significant-control filings on the public register.
Previous registered addresses 2
| Address | Changed on |
|---|---|
| 5TH FLOOR 34 DOVER STREET, LONDON, W1S 4NG, UNITED KINGDOM | 2014-07-03 |
| 83 VICTORIA STREET, SUITE 407, LONDON, SW1H 0HW, UNITED KINGDOM | 2010-11-04 |
The class of 2010
21%
of the 376,892 companies incorporated in 2010 are still active today; 77% have since been dissolved.
A fact about the year, not a forecast for this company.